Medical Health & Life Science Research News

Research delivers insight into the infectious diseases US's market expected to grow at CAGR 3.37 % and forecast to 2019

Research delivers insight into the infectious diseases US's market expected to grow at CAGR 3.37 % and forecast to 2019

Human beings are prone to various kinds of infections. Infectious diseases are caused by various pathogenic microorganisms such as bacteria, fungi, parasites, and viruses.

- Advertisement -

- Restart your WhaTech membership at anytime. -

Infectious Diseases SWOT Anal…nbsp;And Forecast Make an Inquiry about this news

About Infectious Diseases 
Antimicrobials are used to treat infections. They act by killing or resisting the growth of the microorganisms.

They either act via the host defense system or directly target the causative agent. Based on the target organism, antimicrobials can be classified into anti-bacterial, anti-viral, anti-fungal, and anti-parasitic drugs.

- Advertisement -

- Restart your WhaTech membership at anytime. -


Technavio's analysts forecast the infectious diseases market in US to grow at a CAGR of 3.37% over the period 2014-2019. 


Covered in this Report 
This report covers the present scenario and the growth prospects of the infectious diseases market in US for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of drugs administered to treat infectious diseases caused by bacteria, viruses, fungi, and parasites. 
The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the infectious diseases market in US. In addition, it discusses the major drivers that influence the growth of the market.

It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. 


Technavio's report, Infectious Diseases Market in US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. In addition, it discusses the major drivers that influence the growth of the market, challenges faced by the vendors and the market at large, as well as the key trends that contribute to the growth the market. 

 Request For Sample Report @ www.wiseguyreports.com/sample-requ…t-in-us-2015-2019 Make an Inquiry about this news                                                                                     

Key Vendors 
• F. Hoffmann-La Roche 
• Gilead Sciences 
• GlaxoSmithKline 
• Johnson & Johnson 
• Merck 
• Pfizer 
Other Prominent Vendors 

• AbbVie 
• Astellas Pharma 
• AstraZeneca 
• Bayer 
• Bristol-Myers Squibb 
• Chimerix Pharmaceuticals 
• Cubist 
• Eli Lilly 
• Isis Pharmaceuticals 
• Mitsubishi Tanabe Pharma 
• Novartis 
• Sanofi 
• Vertex 
Market Driver 
• Rise in patient population 
• For a full, detailed list, view our report 
Market Challenge 
• Generic erosion 
• For a full, detailed list, view our report 
Market Trend 
• Emergence of IFN-free therapies 
• For a full, detailed list, view our report 
Key Questions Answered in this Report 
• What will the market size be in 2019 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

 Complete Report Details @ www.wiseguyreports.com/reports/591…t-in-us-2015-2019 Make an Inquiry about this news                                                                                                                                                              

Table Of Contents

  1. Executive Summary 
    02. List of Abbreviations 
    03. Scope of the Report 
        
    03.1 Market Overview 
        03.2 Product Offerings 
    04. Market Research Methodology 
        
    04.1 Market Research Process 
        04.2 Research Methodology 
    05. Introduction 
    06. Market Landscape 
        
    06.1 Market Overview 
        06.2 Market Size and Forecast 
          06.2.1 Market Penetration 
          06.2.2 Marketing Approvals 
          06.2.3 Patent Protection 
          06.2.4 Regulatory Designation 
          06.2.5 Orphan Drug Designation 
          06.2.6 WHO Recognition 
          06.2.7 Other Factors 
        06.3 Five Forces Analysis 
    07. Epidemiology 
    07.1 Viral Infections 
        07.2 Fungal Infections 
        07.3 Bacterial Infections 
        07.4 Parasitic Infections
    08. Market Segmentation by Type of Drug 
        08.1 Anti-bacterial Drugs 
          08.1.1 Anti-bacterial Drugs Market in US 
        08.2 Anti-viral Drugs 
          08.2.1 Anti-viral Drugs Market in US 
        08.3 Anti-fungal Drugs 
          08.3.1 Anti-fungal Drugs Market in US 
        08.4 Anti-parasitic Drugs 
          08.4.1 Anti-parasitic Drugs Market in US 
    09. Market Segmentation by Route of Administration 
        09.1 Oral 
        09.2 Parenteral 
        09.3 Topical 
    10. Buying Criteria 
    11. Market Growth Drivers 
    12. Drivers and their Impact 
    13. Market Challenges 
    14. Impact of Drivers and Challenges 
    15. Market Trends 
    16. Trends and their Impact 
    17. Vendor Landscape 
        
    17.1 Competitive Scenario 
          17.1.1 Key News 
          17.1.2 Mergers and Acquisitions 
        17.2 Market Share Analysis 2014 
          17.2.1 Gilead Sciences 
          17.2.2 Johnson & Johnson 
          17.2.3 Merck 
          17.2.4 Pfizer 
          17.2.5 F. Hoffmann-La Roche 
          17.2.6 GlaxoSmithKline 
        17.3 Other and Future Prominent Vendors 
    18. Key Vendor Analysis 
        
    18.1 F. Hoffmann-La Roche Ltd. 
          18.1.1 Key Facts 
          18.1.2 Business Overview 
          18.1.3 Business Segmentation 
          18.1.4 Business Segmentation by Revenue 2012 and 2013 
          18.1.5 Sales by Geography 
          18.1.6 Business Strategy 
          18.1.7 Key Information 
          18.1.8 SWOT Analysis 
        18.2 Gilead Sciences 
          18.2.1 Key Facts 
          18.2.2 Business Overview 
          18.2.3 Geographical Segmentation by Revenue 2013 
          18.2.4 Recent Developments 
          18.2.5 SWOT Analysis 
        18.3 GlaxoSmithKline 
          18.3.1 Key Facts 
          18.3.2 Business Overview 
          18.3.3 Business Segmentation by Revenue 2014 
          18.3.4 Business Segmentation by Revenue 2013 and 2014 
          18.3.5 Geographical Segmentation by Revenue 2014 
          18.3.6 Business Strategy 
          18.3.7 Recent Developments 
          18.3.8 SWOT Analysis 
        18.4 Johnson & Johnson 
          18.4.1 Key Facts 
          18.4.2 Business Overview 
          18.4.3 Business Segmentation by Revenue 2014 
          18.4.4 Business Segmentation by Revenue 2013 and 2014 
          18.4.5 Geographical Segmentation by Revenue 2014 
          18.4.6 Business Strategy 
          18.4.7 Recent Developments 
          18.4.8 SWOT Analysis 
        18.5 Merck 
          18.5.1 Key Facts 
          18.5.2 Business Overview 
          18.5.3 Business Segmentation by Revenue 2013 
          18.5.4 Business Segmentation by Revenue 2012 and 2013 
          18.5.5 Sales by Geography 
          18.5.6 Business Strategy 
          18.5.7 Key Developments 
          18.5.8 SWOT Analysis 
        18.6 Pfizer 
          18.6.1 Key Facts 
          18.6.2 Business Overview 
          18.6.3 Business Segmentation by Revenue 2014 
          18.6.4 Business Segmentation by Revenue 2013 and 2014 
          18.6.5 Geographical Segmentation by Revenue 2014 
          18.6.6 Business Strategy 
          18.6.7 Key Developments 
          18.6.8 SWOT Analysis 
    19. Other Reports in this Series 

 Continued…….

Access This Report @ www.wiseguyreports.com/checkout?cu…p;report_id=59149 Make an Inquiry about this news                                                                                                                                                                 

 

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...

For more information:

Make an Inquiry about this report HERE!
  • www.wiseguyreports.com/sample-requ…t-in-us-2015-2019
  • www.wiseguyreports.com/reports/591…t-in-us-2015-2019
  • www.wiseguyreports.com/checkout?cu…p;report_id=59149